Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...

Epilepsy is a neurological disorder that affects millions of people worldwide, causing recurring seizures that can vary widely in intensity and frequency. For those diagnosed with epilepsy, as well as ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

The AAN’s first-ever functional seizure guideline targets stigma and unnecessary treatment, offering clearer diagnostic steps ...

According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known. The discovery deepens understanding of the symptoms ...

Individuals with focal onset epilepsy treated with azetukalner experienced sustained monthly seizure reduction and evidence of seizure freedom up to 48 months, according to data presented at the ...

CHARLESTON COUNTY, S.C. (WCIV) — November is epilepsy awareness month, which is a time for patients and healthcare professionals to educate others about the condition. One Lowcountry epilepsy patient ...

—After ruling out seizure mimics and seizures caused by an acute trigger, the remaining patients with unprovoked seizure require a further assessment. Here are some details. Reviewed by Aaron Miller, ...

AI helped identify patients with drug-resistant epilepsy who might benefit from surgery, and it highlighted missing tests and ...

Temporal lobe epilepsy, which results in recurring seizures and cognitive dysfunction, is associated with premature aging of ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...